title: Electroconvulsive Therapy in Women: A Retrospective Study from a Mental Health Hospital in Turkey.
abstract: The aim was to evaluate the clinical profile and effectiveness of ECT in women. A retrospective chart review was carried out to identify female patients who had received ECT during the period September 2013-February 2015. Details regarding their sociodemographic, clinical, and treatment data were extracted from these records for the present study. The total number of patients, admitted to our psychiatry inpatient clinic during the survey period, was 802. During this period, 26 (3.24 %) female patients received ECT. Patients who received ECT were mostly in age group of 25-44 years (76.9 %). Twenty percent of patients were in the postpartum period. Psychotic disorders (46.1 %) was the most common diagnosis for which ECT was used, followed by bipolar affective disorder, current episode manic (19.2 %). At the end of ECT courses, 70 % of the patients showed good response with a CGI-I of 1 or 2, and 30 % showed minimal response with a CGI-I score of 3. The most common side effects were post-ECT confusion (15.4 %) and prolonged seizure (11.5 %). This rate of prolonged seizure was higher the rates reported in the literature. The bronchospasm related with remifentanil, post-ECT bradycardia, hypertensive crisis and oligohydramnios were also reported in one case each. ECT is a safe and effective treatment option in women with severe psychiatric disorders and disorders in the perinatal/postpartum period are a major area of ECT use. The female gender may be a contributing factor for the higher rates of prolonged seizure.
authors.affiliation: Bakırköy Mazhar Osman Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, Demirkapı Cad. No:1 H-1B Blok Zuhratbaba/Bakırköy, Istanbul, Turkey. armioz@yahoo.com.
authors.forename: Armağan
authors.initials: A
authors.lastname: Özdemir
authors.affiliation: Department of Psychiatry, Cerrahpaşa Faculty of Medicine, University of Istanbul, Istanbul, Turkey.
authors.forename: Cana Aksoy
authors.initials: CA
authors.lastname: Poyraz
authors.affiliation: Bakırköy Mazhar Osman Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, Demirkapı Cad. No:1 H-1B Blok Zuhratbaba/Bakırköy, Istanbul, Turkey.
authors.forename: Evrim
authors.initials: E
authors.lastname: Erten
authors.affiliation: Bakırköy Mazhar Osman Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, Demirkapı Cad. No:1 H-1B Blok Zuhratbaba/Bakırköy, Istanbul, Turkey.
authors.forename: Emre
authors.initials: E
authors.lastname: Çırakoğlu
authors.affiliation: Bakırköy Mazhar Osman Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, Demirkapı Cad. No:1 H-1B Blok Zuhratbaba/Bakırköy, Istanbul, Turkey.
authors.forename: Nesrin
authors.initials: N
authors.lastname: Tomruk
mesh_terms: D000328:Adult; D000368:Aged; D018686:Anesthetics, Intravenous / Q000009:adverse effects; D001714:Bipolar Disorder / Q000628:therapy*; D001919:Bradycardia / Q000209:etiology; D001986:Bronchial Spasm / Q000139:chemically induced; D019052:Depression, Postpartum / Q000628:therapy; D003866:Depressive Disorder / Q000628:therapy*; D004565:Electroconvulsive Therapy / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006778:Hospitals, Psychiatric; D006801:Humans; D006973:Hypertension / Q000209:etiology; D008875:Middle Aged; D016104:Oligohydramnios / Q000209:etiology; D010880:Piperidines / Q000009:adverse effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy*; D011618:Psychotic Disorders / Q000628:therapy*; D011644:Puerperal Disorders / Q000628:therapy*; D000077208:Remifentanil; D012189:Retrospective Studies; D016896:Treatment Outcome; D014421:Turkey; D055815:Young Adult
chemical_list: D018686:Anesthetics, Intravenous; D010880:Piperidines; D000077208:Remifentanil
keywords: ECT; Female; Prolonged seizure; Psychiatric disorders; Women